Karina Gasbarrino, PhD

Karina Gasbarrino, PhD has a diverse range of work experience. Karina is currently working as a Postdoctoral Research Fellow at the Research Institute of the MUHC / McGill Genome Centre, a position they have held since June 2019. In addition to their postdoctoral role, Karina is also a Co-Founder and COO at PLAKK Inc., a company utilizing artificial intelligence and deep learning to revolutionize the characterization of atherosclerotic plaques. Karina has been involved with PLAKK Inc. since December 2019 and will continue until December 2022.

Before their current positions, Karina worked as a PhD Candidate in the Vascular Health Unit at the RI-MUHC | Research Institute of the MUHC from September 2014 to May 2019. Karina'swork focused on developing and managing a bio-bank of human carotid plaque specimens, blood samples, and isolated primary cells to identify biomarkers and mechanisms of carotid atherosclerotic plaque instability and stroke risk. Karina also conducted research on the role of the adipokine adiponectin and its receptor pathway in atherosclerotic plaque instability.

Karina's work experience also includes a role as a Research Assistant at the McGill Auditory Sciences Lab at the Montreal Children's Hospital from June 2010 to September 2011. In this position, they assisted and trained graduate students in conducting experiments on animal models to understand the mechanism of ototoxicity of cisplatinum and find possible ways to prevent hearing loss caused by this chemotherapeutic agent. Karina performed hearing assessments and processed cochleae for histological evaluation.

Karina's work experience demonstrates their expertise in various areas ranging from genomics and cardiovascular research to auditory sciences.

Karina Gasbarrino, PhD has a diverse education history. Karina started their academic journey in 2009 at McGill University, where they pursued a Bachelor's degree in Cell Biology and Anatomy. Karina successfully completed this program in 2012.

Karina then continued their education at McGill University, specializing in Experimental Medicine - Cardiovascular. Karina enrolled in the Doctor of Philosophy (PhD) program in 2014 and concluded their studies in 2019. During this period, they conducted research and gained expertise in the field of Experimental Medicine - Cardiovascular.

In 2020, Karina Gasbarrino joined Université de Montréal for the Life Sciences Entrepreneurship Development Program, which they completed in 2021. Unfortunately, the details regarding the specific field of study for this program are not provided.

Moreover, Karina Gasbarrino obtained an additional certification in Principles of Laboratory Radiation Safety from McGill University in June 2017.